openPR Logo
Press release

Recent Study on Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

05-04-2017 03:06 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Rheumatoid Arthritis

Recent Study on Rheumatoid Arthritis - Cytokine Mediators

Researchmoz added Most up-to-date research on "Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation" to its huge collection of research reports.
Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable auto-immune disease that affects the joints, and is characterized by synovial inflammation and hyperplasia. It occurs when a number of aberrant cell signaling events trigger chronic inflammation of the synovium – the soft tissue of the joint – leading to pain, joint stiffness, and eventually deformity and disability.

With the disease affecting 0.3–1.0% of the global population, the societal and economic costs of RA are substantial. The large target patient population and the relatively high annual cost of therapy have resulted in a crowded, highly lucrative market.

Treatment options have improved and diversified substantially over the past two decades, largely owing to the advent of biologics. Despite this, considerable unmet needs remain within RA. Consequently, opportunities for future drug developments remain significant, particularly for first-in-class innovation, which is the area most likely to produce substantial clinical advances.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=799450

Scope

- Treatment options for RA have advanced over the past two decades, resulting in a crowded, competitive market landscape.
- What is the pathophysiology of RA?
- Which products and therapeutic strategies dominate the clinical and commercial landscapes?
- What are the most significant unmet needs within the RA market?
- Considerable diversification from current market trends is evident within the RA pipeline.
- Which molecular targets are most prominent within the pipeline?
- What proportion of pipeline products are first in class?
- Which first-in-class targets are most promising?
- Deal values for licensing and co-development deals vary considerably.
- How many strategic consolidations have been completed in the past decade?
- Which types of assets attract the largest deal values?
- Which first-in-class pipeline products have no prior involvement in licensing or co-development deals?

Reasons To Buy

This report will allow you to:
- Appreciate the current clinical and commercial landscapes by considering disease pathogenesis, etiology, epidemiology, symptoms, co-morbidities and complications, diagnosis, and treatment options.
- Visualize the composition of the RA landscape, including key unmet needs, in order to gain a competitive understanding of gaps in the current market.
- Recognize innovative pipeline trends by analyzing therapies by stage of development, molecule type and molecular target.
- Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, all first-in-class targets in the RA pipeline have been assessed and ranked according to clinical potential. Promising early-stage targets have been further reviewed in greater detail.
- Identify first-in-class pipeline products with no prior involvement in licensing and co-development deals that may represent potential investment opportunities.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=799450

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Recent Study on Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation here

News-ID: 524102 • Views:

More Releases from Rheumatoid Arthritis

Overview of Rheumatoid Arthritis : Market Development, Analysis and Demand 2017
Overview of Rheumatoid Arthritis : Market Development, Analysis and Demand 2017
Albany, NY, 5th December : Recent research and the current scenario as well as future market potential of "Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation" globally. Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable auto-immune disease that affects the joints, and is characterized by synovial inflammation and hyperplasia. Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=799450 It occurs when a number of
Rheumatoid Arthritis Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast
Rheumatoid Arthritis Market: Global Industry Analysis, Size, Share, Growth, Tren …
Researchmoz added Most up-to-date research on "Rheumatoid Arthritis Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast" to its huge collection of research reports. Rheumatoid Arthritis Market Arthritis means inflammation in a joint. Inflammation is a normal immune response in a body. It happens when the body, no longer has the ability to turn off the inflammatory response and thereby start damaging the healthy tissues of the body. This inflammation causes
Worldwide Arthritis - EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2025
Worldwide Arthritis - EpiCast Report: Rheumatoid Arthritis - Epidemiology Foreca …
"EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2025" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- ** Summary Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the bodys immune system attacks the lining of the joints, known as
Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation | Now Available at Researchmoz.us
Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors …
Researchmoz added Most up-to-date research on "Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation" to its huge collection of research reports. Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable auto-immune disease that affects the joints, and is characterized by synovial inflammation and hyperplasia. It occurs when a number of aberrant cell signaling events trigger chronic inflammation of the synovium – the soft tissue

All 5 Releases


More Releases for Cytokine

Cytokine Market Global Report 2022-2027: Industry Size, Share, Trends, Growth an …
The latest research study "Cytokine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the global cytokine market size reached US$ 76.67 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 121.25 Billion by 2027 exhibiting a CAGR of 7.80% during 2022-2027. Covid-19 Impact: We are regularly tracking the direct effect of COVID-19 on the market, along
Cytokine Storm Market To Lift Up Industry Growth 2021-2028
The research report published by Index Markets Research provides detailed information on the 𝐂𝐲𝐭𝐨𝐤𝐢𝐧𝐞 𝐒𝐭𝐨𝐫𝐦 market worldwide. In addition to the accessibility of the articles, which drive their worldwide reception, the report identifies the worldwide recognition of the articles as a further development factor. The Global Cytokine Storm Market report provides a brief overview of the main players, their products, the most important events and how they want to benefit
Creative BioMart Released Intracellular Cytokine Detection and Activity Assay fo …
As a global specialized Contract Research Organization providing high-quality protein analytical services to support research, manufacturing and clinical development of native and recombinant proteins, Creative BioMart recently released Intracellular Cytokine Detection and Activity Assay to help explore new frontiers in biological science. Cytokines are small proteins with a wide range of biological activities, in immune cells (e.g., monocytes, macrophages, T cells, B cells, NK cells, etc.) and some non-immune cells (endothelial
South America Cytokine Market Outlook to 2024 published by Envision Inteligence
Summary of the Report: South America Cytokine Market study by Envision Inteligence discusses in detail about diverse market dynamics influencing the market and covers the leading market players and competitive highlights and trends prevailing over the years. The report “South America Cytokine market” is expected to reach USD XX Billion by the year 2024, at a CAGR of XX% during forecast period. The factors that drive the growth of the market
Europe Cytokine Market Size, Share, Trends, Outlook, Growth And Industry Analysi …
Summary of the Report: Europe Cytokine Market study by Envision Inteligence discusses in detail about diverse market dynamics influencing the market and covers the leading market players and competitive highlights and trends prevailing over the years. The report “Europe Cytokine Market” is expected to reach USD XX Billion by the year 2024, at a CAGR of X% during forecast period. The factors that drive the growth of the market are
Cytokine Based Therapies and Inhibitors Market | Current and Future Trends, 2025
Cytokines are produced by broad range of cells including cells of immune system of human body with respect to complex immune responses. Cytokines aid in intercellular communication in immune response because they are cell signaling molecules and trigger the movement of cells toward sites of inflammation, infection and trauma. Cytokines can be categorized as peptides, proteins, and glycoproteins. Cytokines and their receptors are used in various treatment therapies for inflammatory